SCAI 2020: Top Interventional Takeaways
In a recent Cardiology article, M. Chadi Alraies, MD, FACC, discusses the top interventional takeaways from SCAI 2020 Virtual.
The ISCHEMIA trial continues to create a buzz at every interventional meeting. For SCAI 2020 Virtual, it was the ISCHEMIA LM substudy, focused on moderate left main disease, which was excluded in the main trial.
Other popular takeaways included TWILIGHT-SYNERGY, OMEF, the SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease, and more. Read more about the meeting.